Platelet‐to‐lymphocyte ratio predicts the prognosis of patients with non‐small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy

BACKGROUND: Markers of preoperative tumor immunity, such as platelet‐to‐lymphocyte ratio (PLR), have been reported to be prognostic factors for patients with various cancers. However, the relationship between PLR and the prognosis of non‐small cell lung cancer (NSCLC) patients treated with surgery a...

Descripción completa

Detalles Bibliográficos
Autores principales: Toda, Michihito, Tsukioka, Takuma, Izumi, Nobuhiro, Komatsu, Hiroaki, Okada, Satoshi, Hara, Kantaro, Miyamoto, Hikaru, Ito, Ryuichi, Shibata, Toshihiko, Nishiyama, Noritoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754286/
https://www.ncbi.nlm.nih.gov/pubmed/29105365
http://dx.doi.org/10.1111/1759-7714.12547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754286/
https://www.ncbi.nlm.nih.gov/pubmed/29105365
http://dx.doi.org/10.1111/1759-7714.12547

Ejemplares similares